Delivery Order SPE2DB20D9135-SPE2DB23FZW71
- Not listed
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The contract, with a ceiling value of $2,157, is for the delivery of various pharmaceutical products, including flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, contraceptives, oncology...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $4,174.50 firm fixed-price delivery order contract is for the supply of pharmaceutical products, including medications like flumazenil injections, prednisone tablets, and epinephrine auto-injectors, to support the medical needs of Department of Defense (DoD) healthcare facilities...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC) valued up to $499,999,999. The contract covers the delivery of various pharmaceutical products, including flumazenil injections, prednisone tablets, ampicillin injections, and specialized medications, to support the recurring medical supply needs of Department of Defense (DoD)...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a Firm Fixed Price delivery order contract issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The award, valued at $5,078.15, covers the supply of various pharmaceutical products including flumazenil injections, prednisone tablets, ampicillin injections, and other common and specialized medications to support the recurring medical supply needs...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) for the supply of various pharmaceutical products, including medications such as flumazenil injections, prednisone tablets, ampicillin injections, and others. The contract, valued at up to $1,524.07, is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group holds a significant indefinite...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The award, valued at $1,238.99, is for the delivery of various pharmaceutical products, including flumazenil injections, prednisone tablets, ampicillin injections, and other common medications, as well as specialized drugs and medical supplies. The contract has a firm fixed-price pricing type and an ultimate completion date...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The single-award indefinite delivery contract (IDC), valued at up to $499,999,999, allows the DLA to place firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including both common and specialized drugs, to fulfill the recurring medical supply needs of military health facilities...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC) valued up to $499,999,999. The award, with a total ceiling value of $11,269.80 and a completion date of June 12, 2024, is for the supply of various pharmaceutical products, including flumazenil injections, prednisone tablets, ampicillin injections,...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $11,849.81. The award was issued by the Defense Logistics Agency (DLA) under the SPE2DB program, a single-award indefinite delivery contract (IDC) valued up to $499,999,999 that runs through December 31, 2025. Under this IDC, DMS Pharmaceutical Group provides a comprehensive range of pharmaceutical items, from common medications to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,098.43 firm fixed-price delivery order is for the provision of various pharmaceutical products, including medications such as flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, and oncology drugs. DMS Pharmaceutical Group holds a...
- SPE2DB20D9135Indefinite Delivery Contract
- SPE2DB20D9135-SPE2DB23FZW71Delivery Order
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $18,318.75 firm fixed-price delivery order contract is for the supply of pharmaceutical products, including medications such as flumazenil injections, prednisone tablets, and oncology drugs, to support the recurring medical needs of military health facilities worldwide. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items. This IDC, which runs through December 31, 2025, solidifies DMS Pharmaceutical Group's position as a crucial supplier in the federal pharmaceutical supply chain, providing both routine and critical medications to Department of Defense healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.3k | 7/19/23 |